Login to Your Account

It's the Glucose Economy, Stupid

Clotbusting Powers of tPA: Beside the Point in Stroke?

By Anette Breindl
Science Editor

Thursday, July 19, 2012
Tissue-plasminogen activator (tPA, sold as Activase by Roche AG) is the only stroke treatment that has made it to the market at all, amidst a bevy of failed attempts to develop additional stroke drugs. But its limitations are twofold.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription